These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9520413)

  • 21. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.
    Gille J; Khalik M; König V; Kaufmann R
    J Invest Dermatol; 1998 Dec; 111(6):1160-5. PubMed ID: 9856833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.
    Krupski T; Harding MA; Herce ME; Gulding KM; Stoler MH; Theodorescu D
    Growth Factors; 2001; 18(4):287-302. PubMed ID: 11519827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
    Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
    Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
    Zhang X; Gaspard JP; Chung DC
    Cancer Res; 2001 Aug; 61(16):6050-4. PubMed ID: 11507052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice.
    Kanayama H; Yano S; Kim SJ; Ozawa S; Ellis LM; Fidler IJ
    Clin Exp Metastasis; 1999; 17(10):831-40. PubMed ID: 11089881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of angiogenesis in human colorectal carcinoma and its modulation by p53 and K-ras gene].
    Zhong SS; Zhang ZS; Li SM; Deng HJ; Ma Q
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):77-80. PubMed ID: 12783699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
    Gille J; Swerlick RA; Caughman SW
    EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
    Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma.
    Nakashima T; Hudson JM; Clayman GL
    Head Neck; 2000 Aug; 22(5):483-8. PubMed ID: 10897108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.
    Abe K; Shoji M; Chen J; Bierhaus A; Danave I; Micko C; Casper K; Dillehay DL; Nawroth PP; Rickles FR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8663-8. PubMed ID: 10411932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
    Grunstein J; Roberts WG; Mathieu-Costello O; Hanahan D; Johnson RS
    Cancer Res; 1999 Apr; 59(7):1592-8. PubMed ID: 10197634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.
    Mori A; Arii S; Furutani M; Hanaki K; Takeda Y; Moriga T; Kondo Y; Gorrin Rivas MJ; Imamura M
    Int J Cancer; 1999 Mar; 80(5):738-43. PubMed ID: 10048976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.
    Tang YC; Li Y; Qian GX
    World J Gastroenterol; 2001 Feb; 7(1):22-7. PubMed ID: 11819727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.